Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 256

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 256
---
) | Consists                                                                                                      
 of 938 shares of Common Stock issuable pursuant to stock options exercisable within 60 days of June 30, 2025. |

| (5) | Consists                                                                                                                                        
 of (i) 63 shares of Common Stock, (ii) 24,528 shares of Common Stock, held by the Atwood-Edminster Trust dtd 4-2-2000 (the “Trust”),            
 of which Mr. Atwood and Lynne H. Edminster serve as trustees (iii) 1,331 shares of Common Stock, issuable pursuant to stock options exercisable 
 within 60 days of June 30, 2025 and (iv) shares underlying 10,787 Pre-Funded Warrants held by Mr. Atwood and GVN, LLC, which is the maximum     
 number of such Pre-Funded Warrants held thereby that may be exercised without exceeding the beneficial ownership limitations set forth          
 therein. Excludes warrants and/or pre-funded warrants held by Mr. Atwood and GVN, LLC (of which Mr. Atwood and Lynne H. Edminster serve         
 as managers, and the sole member is the Trust) that are in excess of the applicable beneficial ownership limitations.                           |

| (6) | Consists                                                                                                      
 of 682 shares of Common Stock issuable pursuant to stock options exercisable within 60 days of June 30, 2025. |

| (7) | Consists                                                                                                                                 
 of (i) 3 shares of Common Stock held by Kathleen LaPorte, (ii) 483 shares of Common Stock, held by the Kathleen LaPorte Revocable Trust, 
 of which Ms. LaPorte serves as a trustee, and (iii) 682 shares of Common Stock issuable pursuant to stock options exercisable within     
 60 days of June 30, 2025.                                                                                                                |

| (8) | Consists                                                                                                      
 of 682 shares of Common Stock issuable pursuant to stock options exercisable within 60 days of June 30, 2025. |

| (9) | Consists                                                                                                      
 of 634 shares of Common Stock issuable pursuant to stock options exercisable within 60 days of June 30, 2025. |

146 SELLING SECURITYHOLDER This prospectus relates to the possible resale from time to time by the Selling Securityholder of up to 12,500,000 shares of our Common Stock that have or may be